The helix 1-3 loop in the glucocorticoid receptor LBD is a regulatory element for FKBP cochaperones

Molecular Endocrinology

Volumn 27, Issue 7, 2013, Pages 1020-1035

  Cluning, Carmel ^a,b   Ward, Bryan K ^a,b   Rea, Sarah L ^a,b   Arulpragasam, Ajanthy ^a,b   Fuller, Peter J ^c   Ratajczak, Thomas ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; FK 506 BINDING PROTEIN; FK506 BINDING PROTEIN 52; GLUCOCORTICOID RECEPTOR; HEAT SHOCK PROTEIN 90; PEPTIDYLPROLYL ISOMERASE; UNCLASSIFIED DRUG;

ALPHA HELIX; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; ENZYME ACTIVITY; FIBROBLAST; HELIX 1; HELIX 2; HELIX 3; HUMAN; HUMAN CELL; LIGAND BINDING; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS REGULATION; SACCHAROMYCES CEREVISIAE;

AMINO ACID SEQUENCE; ANIMALS; CONSERVED SEQUENCE; GUINEA PIGS; HEK293 CELLS; HELA CELLS; HUMANS; MICE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; MUTATION; PROLINE; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTORS, ANDROGEN; RECEPTORS, GLUCOCORTICOID; REGULATORY SEQUENCES, NUCLEIC ACID; SACCHAROMYCES CEREVISIAE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STRUCTURE-ACTIVITY RELATIONSHIP; TACROLIMUS BINDING PROTEINS;

CAVIA; RATTUS; SACCHAROMYCES CEREVISIAE;

EID: 84879468459     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1023     Document Type: Article

References (100)

1. Evans RM. The steroid and thyroid hormone receptor superfamily. Science. 1988;240:889-895.
2. Fuller P. The steroid receptor superfamily: mechanisms of diversity. FASEB J. 1991;5:3092-3099.
3. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell. 1995;83:835-839.
4. Cole TJ, Blendy JA, Monaghan AP, et al. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 1995;9:1608-1621.
5. de Kloet ER, Joëls M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci. 2005;6:463-475.
6. Funder JW, Sheppard K. Adrenocortical steroids and the brain. Annu Rev Physiol. 1987;49:397-411.
7. Heitzer MD, Wolf IM, Sanchez ER, Witchel SF, DeFranco DB. Glucocorticoid receptor physiology. Rev Endocr Metab Disord. 2007;8:321-330.
8. McKay LI, Cidlowski JA. Molecular control of immune/inflammatory responses: interactions between nuclear factor-κB and steroid receptor-signaling pathways. Endocr Rev. 1999;20:435-459.
9. Peeke PM, Chrousos GP. Hypercortisolism and obesity. Ann N Y Acad Sci. 1995;771:665-676.
10. Reichardt HM, Kaestner KH, Tuckermann J, et al. DNA binding of the glucocorticoid receptor is not essential for survival. Cell. 1998;93:531-541.
11. Vegiopoulos A, Herzig S. Glucocorticoids, metabolism and metabolic diseases. Mol Cell Biol. 2007;275:43-61.
12. Bledsoe RK, Montana VG, Stanley TB, et al. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell. 2002;110:93-105.
13. Savory JG, Préfontaine GG, Lamprecht C, et al. Glucocorticoid receptor homodimers and glucocorticoid-mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces. Mol Cell Biol. 2001;21:781-793.
14. Pratt WB, Toft DO. Regulation of signaling protein function and trafficking by the Hsp90/Hsp70-based chaperone machinery. Exp Biol Med. 2003;228:111-133.
15. Ratajczak T, Ward BK, Minchin RF. Immunophilin chaperones in steroid receptor signalling. Curr Top Med Chem. 2003;3:1348-1357.
16. Riggs DL, Cox MB, Cheung-Flynn J, Prapapanich V, Carrigan PE, Smith DF. Functional specificity of co-chaperone interactions with Hsp90 client proteins. Crit Rev Biochem Mol Biol. 2004;39:279-295.
17. Smith DF, Toft DO. The intersection of steroid receptors with molecular chaperones: observations and questions. Mol Endocrinol. 2008;22:2229-2240.
18. Beato M, Herrlich P, Schützb G. Steroid hormone receptors: many actors in search of a plot. Cell. 1995;83:851-857.
19. Karin M. New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell. 1998;93:487-490.
20. Bamberger CM, Schulte HM, Chrousos GP. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev. 1996;17:245-261.
21. Kino T, Vottero A, Charmandari E, Chrousos GP. Familial/sporadic glucocorticoid resistance syndrome and hypertension. Ann N Y Acad Sci. 2002;970:101-111.
22. Chrousos GP, Renquist D, Brandon D, et al. Glucocorticoid hormone resistance during primate evolution: receptor-mediated mechanisms. Proc Natl Acad Sci U S A. 1982;79:2036-2040.
23. Keightley MC, Curtis AJ, Chu S, Fuller PJ. Structural determinants of cortisol resistance in the guinea pig glucocorticoid receptor. Endocrinology. 1998;139:2479-2485.
24. Keightley MC, Fuller PJ. Anomalies in the endocrine axes of the guinea pig: relevance to human physiology and disease. Endocr Rev. 1996;17:30-44.
25. Scammell JG, Denny WB, Valentine DL, Smith DF. Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates. Gen Comp Endocrinol. 2001;124:152-165.
26. Fuller PJ, Smith BJ, Rogerson FM. Cortisol resistance in the New World revisited. Trends Endocrinol Metab. 2004;15:296-299.
27. Denny WB, Prapapanich V, Smith DF, Scammell JG. Structurefunction analysis of Squirrel Monkey FK506-binding protein 51, a potent inhibitor of glucocorticoid receptor activity. Endocrinology. 2005;146:3194-3201.
28. Denny WB, Valentine DL, Reynolds PD, Smith DF, Scammell JG. Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology. 2000;141:4107-4113.
29. Reynolds PD, Ruan Y, Smith DF, Scammell JG. Glucocorticoid resistance in the squirrel monkey is associated with overexpression of the immunophilin FKBP51. J Clin Endocrinol Metab. 1999;84: 663-669.
30. Galat A. Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity-targets-functions. Curr Top Med Chem. 2003; 3:1315-1347.
31. Ratajczak T, Cluning C, Ward BK. Steroid receptor contact domains for functional interactions with Hsp90 and its cochaperones. Curr Top Steroid Res. 2009;6:21-31.
32. Sinars CR, Cheung-Flynn J, Rimerman RA, Scammell JG, Smith DF, Clardy J. Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes. Proc Natl Acad Sci U S A. 2003;100:868-873.
33. Wu B, Li P, Liu Y, et al. 3D structure of human FK506-binding protein 52: implications for the assembly of the glucocorticoid receptor/Hsp90/immunophilin heterocomplex. Proc Natl Acad Sci U S A. 2004;101:8348-8353.
34. Barent RL, Nair SC, Carr DC, et al. Analysis of FKBP51/FKBP52 chimeras and mutants for Hsp90 binding and association with progesterone receptor complexes. Mol Endocrinol. 1998;12:342-354.
35. Davies TH, Ning YM, Sánchez ER. Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506. Biochemistry. 2005;44:2030-2038.
36. Nair SC, Rimerman RA, Toran EJ, et al. Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with Hsp90 and progesterone receptor. Mol Cell Biol. 1997;17: 594-603.
37. Ratajczak T, Carrello A, Mark PJ, et al. The cyclophilin component of the unactivated estrogen receptor contains a tetratricopeptide repeat domain and shares identity with p59 (FKBP59). J Biol Chem. 1993;268:13187-13192.
38. Schülke JP, Wochnik GM, Lang-Rollin I, et al. Differential impact of tetratricopeptide repeat proteins on the steroid hormone receptors. PLoS ONE. 2010;5:e11717.
39. Silverstein AM, Galigniana MD, Chen MS, Owens-Grillo JK, Chinkers M, Pratt WB. Protein phosphatase 5 is a major component of glucocorticoid receptor·Hsp90 complexes with properties of an FK506-binding immunophilin. J Biol Chem. 1997;272: 16224-16230.
40. Wochnik GM, Rüegg J, Abel GA, Schmidt U, Holsboer F, Rein T. FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem. 2005;280:4609-4616.
41. Riggs DL, Roberts PJ, Chirillo SC, et al. The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo. EMBO J. 2003;22:1158-1167.
42. Warrier M, Hinds TD Jr, Ledford KJ, et al. Susceptibility to dietinduced hepatic steatosis and glucocorticoid resistance in FK506-binding protein 52-deficient mice. Endocrinology. 2010;151: 3225-3236.
43. Chen H, Yong W, Hinds TD Jr, et al. Fkbp52 regulates androgen receptor transactivation activity and male urethra morphogenesis. J Biol Chem. 2010;285:27776-27784.
44. Cheung-Flynn J, Prapapanich V, Cox MB, Riggs DL, Suarez-Quian C, Smith DF. Physiological role for the cochaperone FKBP52 in androgen receptor signaling. Mol Endocrinol. 2005; 19:1654-1666.
45. Yong W, Yang Z, Periyasamy S, et al. Essential role for co-chaperone FKBP52 but not FKBP51 in androgen receptor-mediated signaling and physiology. J Biol Chem. 2007;282:5026-5036.
46. Tranguch S, Cheung-Flynn J, Daikoku T, et al. Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation. Proc Natl Acad Sci U S A. 2005;102:14326-14331.
47. Yang Z, Wolf IM, Chen H, et al. FK506-binding protein 52 is essential to uterine reproductive physiology controlled by the progesterone receptor A isoform. Mol Endocrinol. 2006;20:2682-2694.
48. Riggs DL, Cox MB, Tardif HL, Hessling M, Buchner J, Smith DF. Noncatalytic role of the FKBP52 peptidyl-prolyl isomerase domain in the regulation of steroid hormone signaling. Mol Cell Biol. 2007;27:8658-8669.
49. De Leon JT, Iwai A, Feau C, et al. Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells. Proc Natl Acad Sci U S A. 2011;108:11878-11883.
50. Estébanez-Perpiñá E, Arnold LA, Nguyen P, et al. A surface on the androgen receptor that allosterically regulates coactivator binding. Proc Natl Acad Sci U S A. 2007;104:16074-16079.
51. Alnemri ES, Litwack G. The steroid binding domain influences intracellular solubility of the baculovirus overexpressed glucocorticoid and mineralocorticoid receptors. Biochemistry. 1993;32: 5387-5393.
52. Nemoto T, Ohara-Nemoto Y, Sato N, Ota M. Dual roles of 90-kDa heat shock protein in the function of the mineralocorticoid receptor. J Biochem. 1993;113:769-775.
53. Aumais JP, Lee HS, Lin R, White JH. Selective interaction of Hsp90 with an estrogen receptor ligand-binding domain containing a point mutation. J Biol Chem. 1997;272:12229-12235.
54. Picard D, Khursheed B, Garabedian MJ, Fortin MG, Lindquist S, Yamamoto KR. Reduced levels of Hsp90 compromise steroid receptor action in vivo. Nature. 1990;348:166-168.
55. Picard D. Chaperoning steroid hormone action. Trends Endocrinol Metab. 2006;17:229-235.
56. Matias PM, Donner P, Coelho R, et al. Structural evidence for ligand specificity in the binding domain of the human androgen receptor: implications for pathogenic gene mutations. J Biol Chem. 2000;275:26164-26171.
57. Williams SP, Sigler PB. Atomic structure of progesterone complexed with its receptor. Nature. 1998;393:392-396.
58. Wurtz JM, Bourguet W, Renaud JP, et al. A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol. 1996;3:87-94.
59. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature. 1995;375:377-382.
60. Davies TH, Ning YM, Sánchez ER. A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins. J Biol Chem. 2002;277:4597-4600.
61. Galigniana MD, Erlejman AG, Monte M, Gomez-Sanchez C, Piwien-Pilipuk G. The Hsp90-FKBP52 complex links the mineralocorticoid receptor to motor proteins and persists bound to the receptor in early nuclear events. Mol Cell Biol. 2010;30:1285-1298.
62. Storer CL, Dickey CA, Galigniana MD, Rein T, Cox MB. FKBP51 and FKBP52 in signaling and disease. Trends Endocrinol Metab. 2011;22:481-490.
63. Wolf IM, Periyasamy S, Hinds T Jr, Yong W, Shou W, Sanchez ER. Targeted ablation reveals a novel role of FKBP52 in genespecific regulation of glucocorticoid receptor transcriptional activity. J Steroid Biochem Mol Biol. 2009;113:36-45.
64. Fang L, Ricketson D, Getubig L, Darimont B. Unliganded and hormone-bound glucocorticoid receptors interact with distinct hydrophobic sites in the Hsp90 C-terminal domain. Proc Natl Acad Sci U S A. 2006;103:18487-18492.
65. Schena M, Yamamoto KR. Mammalian glucocorticoid receptor derivatives enhance transcription in yeast. Science. 1988;241: 965-967.
66. Jinwal UK, Koren J 3rd, Borysov SI, et al. The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules. J Neurosci. 2010;30:591-599.
67. Elhaji YA, Stoica I, Dennis S, et al. Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity. Hum Mol Genet. 2006; 15:921-931.
68. Rennie PS, Bruchovsky N, Leco KJ, et al. Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. Mol Endocrinol. 1993;7:23-36.
69. Allan RK, Mok D, Ward BK, Ratajczak T. Modulation of chaperone function and cochaperone interaction by novobiocin in the C-terminal domain of Hsp90: evidence that coumarin antibiotics disrupt Hsp90 dimerization. J Biol Chem. 2006;281:7161-7171.
70. Vilardell J, Warner JR. Ribosomal protein L32 of Saccharomyces cerevisiae influences both the splicing of its own transcript and the processing of rRNA. Mol Cell Biol. 1997;17:1959-1965.
71. Keightley MC, Fuller PJ. Unique sequences in the guinea pig glucocorticoid receptor induce constitutive transactivation and decrease steroid sensitivity. Mol Endocrinol. 1994;8:431-439.
72. Keightley MC, Fuller PJ. Cortisol resistance and the guinea pig glucocorticoid receptor. Steroids. 1995;60:87-92.
73. Garabedian MJ, Yamamoto KR. Genetic dissection of the signal-ing domain of a mammalian steroid receptor in yeast. Mol Biol Cell. 1992;3:1245-1257.
74. Kralli A, Bohen SP, Yamamoto KR. LEM1, an ATP-binding-cassette transporter, selectively modulates the biological potency of steroid hormones. Proc Natl Acad SciUSA. 1995;92:4701-4705.
75. Bohen SP, Yamamoto KR. Isolation of Hsp90 mutants by screening for decreased steroid receptor function. Proc Natl Acad Sci U S A. 1993;90:11424-11428.
76. Dittmar KD, Demady DR, Stancato LF, Krishna P, Pratt WB. Folding of the glucocorticoid receptor by the heat shock protein (hsp) 90-based chaperone machinery: the role of p23 is to stabilize receptor·Hsp90 heterocomplexes formed by Hsp90·p60·Hsp70. J Biol Chem. 1997;272:21213-21220.
77. Morishima Y, Kanelakis KC, Murphy PJ, et al. The hsp90 cochaperone p23 is the limiting component of the multiprotein hsp90/ hsp70-based chaperone system in vivo where it acts to stabilize the client protein·hsp90 complex. J Biol Chem. 2003;278:48754-48763.
78. Ali MM, Roe SM, Vaughan CK, et al. Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex. Nature. 2006;440:1013-1017.
79. McLaughlin SH, Sobott F, Yao ZP, et al. The co-chaperone p23 arrests the Hsp90 ATPase cycle to trap client proteins. J Mol Biol. 2006;356:746-758.
80. Grad I, McKee TA, Ludwig SM, et al. The Hsp90 cochaperone p23 is essential for perinatal survival. Mol Cell Biol. 2006;26: 8976-8983.
81. Hubler TR, Scammell JG. Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids. Cell Stress Chaperones. 2004;9:243-252.
82. Paakinaho V, Makkonen H, Jääskeläinen T, Palvimo JJ. Glucocorticoid receptor activates poised FKBP51 locus through longdistance interactions. Mol Endocrinol. 2010;24:511-525.
83. Binder EB. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology. 2009;34(Suppl 1): S186-S195.
84. Holownia A, Mroz RM, Kolodziejczyk A, Chyczewska E, Braszko JJ. Increased FKBP51 in induced sputum cells of chronic obstructive pulmonary disease patients after therapy. Eur J Med Res. 2009;14(Suppl 4):108-111.
85. Woodruff PG, Boushey HA, Dolganov GM, et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci U S A. 2007;104:15858-15863.
86. Stechschulte LA, Sanchez ER. FKBP51: a selective modulator of glucocorticoid and androgen sensitivity. Curr Opin Pharmacol. 2011;11:332-337.
87. Dalman FC, Scherrer LC, Taylor LP, Akil H, Pratt WB. Localization of the 90-kDa heat shock protein-binding site within the hormone-binding domain of the glucocorticoid receptor by peptide competition. J Biol Chem. 1991;266:3482-3490.
88. Ricketson D, Hostick U, Fang L, Yamamoto KR, Darimont BD. A conformational switch in the ligand-binding domain regulates the dependence of the glucocorticoid receptor on Hsp90. J Mol Biol. 2007;368:729-741.
89. Kauppi B, Jakob C, Färnegårdh M, et al. The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism. J Biol Chem. 2003;278: 22748-22754.
90. Arriza JL, Weinberger C, Cerelli G, et al. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science. 1987; 237:268-275.
91. Rogerson FM, Dimopoulos N, Sluka P, Chu S, Curtis AJ, Fuller PJ. Structural determinants of aldosterone binding selectivity in the mineralocorticoid receptor. J Biol Chem. 1999;274:36305-36311.
92. Rogerson FM, Yao YZ, Elsass RE, Dimopoulos N, Smith BJ, Fuller PJ. A critical region in the mineralocorticoid receptor for aldosterone binding and activation by cortisol: evidence for a common mechanism governing ligand binding specificity in steroid hormone receptors. Mol Endocrinol. 2007;21:817-828.
93. Nettles KW, Sun J, Radek JT, et al. Allosteric control of ligand selectivity between estrogen receptors α and β: implications for other nuclear receptors. Mol Cell. 2004;13:317-327.
94. Kallenberger BC, Love JD, Chatterjee VK, Schwabe JW. A dynamic mechanism of nuclear receptor activation and its perturbation in a human disease. Nat Struct Biol. 2003;10:136-140.
95. Viguera AR, Serrano L. Stable proline box motif at the N-terminal end of α-helices. Protein Sci. 1999;8:1733-1742.
96. Glass CK, Rosenfeld MG. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 2000;14:121-141.
97. Caamaño CA, Morano MI, Dalman FC, Pratt WB, Akil H. A conserved proline in the Hsp90 binding region of the glucocorticoid receptor is required for Hsp90 heterocomplex stabilization and receptor signaling. J Biol Chem. 1998;273:20473-20480.
98. Pratt WB, Galigniana MD, Harrell JM, DeFranco DB. Role of Hsp90 and the Hsp90-binding immunophilins in signalling protein movement. Cell Signal. 2004;16:857-872.
99. Harris SF, Shiau AK, Agard DA. The crystal structure of the carboxy-terminal dimerization domain of htpG, the Escherichia coli Hsp90, reveals a potential substrate binding site. Structure. 2004; 12:1087-1097.
100. Jackson SE, Queitsch C, Toft D. Hsp90: from structure to phenotype. Nat Struct Mol Biol. 2004;11:1152-1155.